Selvita S.A. Acquires PozLab
May 7, 2024
Selvita S.A. has completed the acquisition of 100% of the shares in PozLab, a Poznan-based CDMO providing drug product development, analytical and microbiological testing, and small pilot plant manufacturing under GMP. The deal expands Selvita's service offering beyond preclinical research into small-molecule drug manufacturing for early-stage clinical trials and strengthens its position in the pharmaceutical research value chain.
- Buyers
- Selvita S.A.
- Targets
- PozLab
- Industry
- Pharmaceuticals
- Location
- Greater Poland Voivodeship, Poland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Cemvita Factory Acquires Solfatara Laboratories
June 14, 2022
Industrial Services
Cemvita Factory acquired Denver-based Solfatara Laboratories to accelerate development and scale-up of its biomining capabilities, including Solfatara’s scale-up facility in Golden, Colorado. Solfatara’s founder Tom Clark joins Cemvita as Head of Biohydrometallurgy to support bioleaching, bio-oxidation and acid mine drainage monitoring work as Cemvita prepares for commercial field deployment of biomining technologies.
-
Kuva Labs Acquires Lisata Therapeutics
March 6, 2026
Pharmaceuticals
Lisata Therapeutics, a clinical-stage pharmaceutical company, entered into a definitive agreement to be acquired by Kuva Labs. Under the terms of the merger agreement, Kuva will commence a tender offer for all outstanding Lisata shares for $5.00 per share in cash plus a contingent value right (CVR) for an additional $1.00 per share upon FDA or governmental acceptance of a related NDA/registration milestone.
-
Beckman Coulter Life Sciences Acquires ValitaCell Ltd.
September 13, 2022
Biotechnology
Beckman Coulter Life Sciences, a Danaher company, has acquired Dublin-based ValitaCell Ltd., a developer of analytical products and technologies for the biopharmaceutical industry. The acquisition adds ValitaCell’s ValitaTiter and related cell-analytics products to Beckman Coulter’s portfolio to accelerate biologics development and manufacturing workflows.
-
Curative Inc. Acquires KorvaLabs, Inc.
May 19, 2020
Healthcare Services
Curative Inc. has acquired KorvaLabs, a CLIA-certified and DEA-licensed analytical laboratory based in San Dimas, California, formalizing a partnership that supported Curative's manufacture and processing of its oral fluid COVID-19 test. The acquisition strengthens Curative's testing capacity — to date the organizations processed 245,371 tests together and were processing roughly 14,000 tests per day — and secures in-house manufacturing and processing capabilities.
-
Solvias Acquires Chemic Laboratories to Establish U.S. Laboratory Presence
June 17, 2021
Healthcare Services
Solvias has acquired Canton, Massachusetts-based Chemic Laboratories, Inc., giving the Swiss analytical testing and contract research company a U.S. foothold and complementary laboratory testing capabilities. Chemic's co-founders will join Solvias' leadership and continue to run U.S. operations; financial terms were not disclosed.
-
Altasciences Acquires Alliance Contract Pharma
February 27, 2020
Pharmaceuticals
Altasciences, a mid-size contract research organization based in Laval, Quebec, has acquired Alliance Contract Pharma to add small-molecule contract manufacturing and analytical services, including commercial manufacturing, GMP warehouse storage, and clinical supply distribution. The acquisition expands Altasciences' integrated early‑phase drug development offering by adding manufacturing and analytical capabilities to its preclinical, clinical, and bioanalytical services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.